Asterias interview: stem cell spinal cord injury trials advance
Recently I had the opportunity to talk with the leadership of Asterias, a California biotech doing exciting clinical research using stem cells as the basis for treatment of spinal cord injury. The interview covers the past (Geron patients), present, and future. I spoke with Asterias President and CEO Stephen Cartt and CMO Edward Wirth. How […]
Asterias interview: stem cell spinal cord injury trials advance Read More »